Wang, Z., Wang, Z., Wang, Z., Wang, Z., Zhang, C., Yin, J., . . . Li, N. (2025). Conversion therapy with TACE, TKIs, and ICIs for unresectable BCLC stage B and C hepatocellular carcinoma. Frontiers Media S.A.
Chicago Style (17th ed.) CitationWang, Zhuoran, et al. Conversion Therapy with TACE, TKIs, and ICIs for Unresectable BCLC Stage B and C Hepatocellular Carcinoma. Frontiers Media S.A, 2025.
MLA (9th ed.) CitationWang, Zhuoran, et al. Conversion Therapy with TACE, TKIs, and ICIs for Unresectable BCLC Stage B and C Hepatocellular Carcinoma. Frontiers Media S.A, 2025.
Warning: These citations may not always be 100% accurate.